Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 September 2022 | Story Leonie Bolleurs | Photo Johané Odendaal and Edward Lee
UFS Solar car
Team UFS entered the Sasol Solar Challenge for the very first time this year, competing with seven other teams and showcasing their technological input and innovation.

Excitement. Nervousness. A thousand thoughts going through our minds, but primarily “Are we really ready for the challenges that lie ahead?” and “What did we get ourselves into?” In the moments leading up to this year’s Sasol Solar Challenge, these were the thoughts and emotions of Team UFS, who entered their solar car, Lengau.

“But I had confidence in the team,” says Dr Hendrik van Heerden from the UFS Department of Physics at the University of the Free State (UFS) and project manager of Team UFS who entered the challenge for the very first time this year.

Testing perseverance

Entering the Sasol Solar Challenge – a biennial competition that has been running since 2008 – Team UFS competed against seven other teams (representing local and international universities, high schools, and engineering teams), sharing the public roads of South Africa with trucks and regular traffic, sometimes experiencing steep mountain climbs, testing not only their technological input and innovation, but also their perseverance over an eight-day period. 

“One of our main challenges was the long time on the road, to which the heavy weight of the solar car, efficiency of the solar panels, and the effective charging of the battery contributed,” says Dr Van Heerden, stating that these problems were difficult to tackle with the small budget they had. “We, however, stayed positive and was determined to pull through.” 

“We were also open for learning from the other teams, the scrutineers, and observers regarding the mechanical, electrical, and body of competing solar cars. Thus, building knowledge and collaborating is a success we celebrate,” he adds.

In the end it paid off, as Team UFS completed the race, covering a distance of more than 500 km and ending in seventh place overall. The team that finished with the greatest distance covered within the allotted time won the challenge, in this instance the Brunel Solar Team, covering 4 228,2 km.

Dr Van Heerden believes that they did exceptionally well for a debut team, proving themselves against the best. “I am of the opinion that this challenge made us stronger and gave each of us a new perspective on how we should approach life,” he adds.

“As we are all enthusiastic about science and engineering, this challenge inspired us to build towards a future where renewable energy could be an important source of energy in South Africa.”
For a debut team, we did exceptionally well, proving ourselves against the best. – Dr Hendrik van Heerden.

Learning the ropes

The teams left Carnival City in Johannesburg on 9 September 2022 and arrived at the finish line at the V&A Waterfront in Cape Town on Friday 16 September 2022.

Talking about the next race, Dr Van Heerden says he wants to build a better, more effective solar car. “We strive to continuously improve the design, technology, and science going into our car,” he says. 

“For this challenge, we were interested in learning about the mechanical, electrical, and overall body of a solar car. Hence, our solar vehicle was designed well enough to participate and reliable enough to succeed.”

According to him, their focus will shift to competing against the other teams for the next Sasol Solar Challenge. “We will also be more prepared, since we now know what to expect from the challenge. It was our first time participating in the Sasol Solar Challenge, and we’ve learnt so much from the past two weeks – we will carry that forward to the next challenge.

 

News Archive

Conference: Expanded ARV treatment
2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

  • ARV Programme as on 24Feb Download Word document
     
  • Programme Special events Download Word document


    Official web site www.fshealth.gov.za/subsites/arvc

     


    Rationale for the Conference
    At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

  • Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
     
  • Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
  • Training and evaluation of training
  • Patients, communities and civil society organisations
  • Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept